开云app官网登录入口网页版-官方正版

#磺脲类#

77篇内容 | 2359人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2206213, encodeId=73142206213ea, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=2ad5104395dc' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a> <a href='/topic/show?id=31618386e18' target=_blank style='color:#2F92EE;'>#胰岛素#</a> <a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a> <a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=强化控糖，终身受益！《柳叶刀》：二甲双胍、胰岛素或磺脲类效用长达44年, objectType=article, longId=827170, objectId=367d82e170d4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240523/1716450310134_5579292.jpg, objectUrl=/article/show_article.do?id=367d82e170d4, replyNumber=0, likeNumber=98, createdTime=2024-05-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=367d82e170d4, moduleTitle=强化控糖，终身受益！《柳叶刀》：二甲双胍、胰岛素或磺脲类效用长达44年, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=367d82e170d4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1442206, encodeId=d42814422064c, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=Diabetes ：GIP和GLP-1增强磺脲类药物诱导肝细胞核因子1a突变携带者的胰岛素分泌, objectType=article, longId=738901, objectId=d917e38901bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d917e38901bd, replyNumber=0, likeNumber=90, createdTime=2022-09-12, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d917e38901bd, moduleTitle=Diabetes ：GIP和GLP-1增强磺脲类药物诱导肝细胞核因子1a突变携带者的胰岛素分泌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d917e38901bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442205, encodeId=d1291442205a9, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-磺脲类药物联合DPP-4抑制剂的疗效, objectType=article, longId=738851, objectId=9b3ae388512b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b3ae388512b, replyNumber=0, likeNumber=64, createdTime=2022-09-11, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b3ae388512b, moduleTitle=【每日播报】-磺脲类药物联合DPP-4抑制剂的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9b3ae388512b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442204, encodeId=8eea1442204e1, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-磺脲类药物联合α-糖苷酶抑制剂的疗效, objectType=article, longId=738850, objectId=a364e388504c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a364e388504c, replyNumber=0, likeNumber=76, createdTime=2022-09-11, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a364e388504c, moduleTitle=【每日播报】-磺脲类药物联合α-糖苷酶抑制剂的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a364e388504c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442203, encodeId=6e181442203e3, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-磺脲类药物联合噻唑烷二酮类药物的疗效, objectType=article, longId=738849, objectId=ad8fe388491a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8fe388491a, replyNumber=0, likeNumber=68, createdTime=2022-09-11, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8fe388491a, moduleTitle=【每日播报】-磺脲类药物联合噻唑烷二酮类药物的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ad8fe388491a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442202, encodeId=9d6f144220272, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-磺脲类药物联合二甲双胍疗效, objectType=article, longId=738848, objectId=2759e388489a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2759e388489a, replyNumber=0, likeNumber=96, createdTime=2022-09-11, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2759e388489a, moduleTitle=【每日播报】-磺脲类药物联合二甲双胍疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2759e388489a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442200, encodeId=df7814422002d, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-常用的磺脲类药物的用法, objectType=article, longId=737875, objectId=b655e3787589, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b655e3787589, replyNumber=0, likeNumber=95, createdTime=2022-09-07, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b655e3787589, moduleTitle=【每日播报】-常用的磺脲类药物的用法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b655e3787589)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442199, encodeId=d21914421998f, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-对于新诊断T2DM患者，磺脲类各药物单药治疗疗效, objectType=article, longId=737874, objectId=5b10e378749f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b10e378749f, replyNumber=0, likeNumber=68, createdTime=2022-09-07, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b10e378749f, moduleTitle=【每日播报】-对于新诊断T2DM患者，磺脲类各药物单药治疗疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5b10e378749f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442198, encodeId=87ee1442198d9, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-常用的磺脲类药物有哪些, objectType=article, longId=737873, objectId=e361e378738e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e361e378738e, replyNumber=0, likeNumber=70, createdTime=2022-09-07, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e361e378738e, moduleTitle=【每日播报】-常用的磺脲类药物有哪些, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e361e378738e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442197, encodeId=bb9c144219eff, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-磺脲类药物如何调整剂量?, objectType=article, longId=737872, objectId=86ebe37872d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86ebe37872d2, replyNumber=0, likeNumber=81, createdTime=2022-09-07, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86ebe37872d2, moduleTitle=【每日播报】-磺脲类药物如何调整剂量?, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=86ebe37872d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442196, encodeId=ae37144219601, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=【每日播报】-磺脲类药物应用注意事项, objectType=article, longId=737871, objectId=9458e37871ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9458e37871ce, replyNumber=0, likeNumber=66, createdTime=2022-09-07, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9458e37871ce, moduleTitle=【每日播报】-磺脲类药物应用注意事项, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9458e37871ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442201, encodeId=542014422012d, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=“二甲双胍+胰岛素”vs“二甲双胍+磺脲类药物”，谁的降糖疗效和心血管结局更好？, objectType=article, longId=737817, objectId=8bdfe378177c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bdfe378177c, replyNumber=0, likeNumber=131, createdTime=2022-09-06, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bdfe378177c, moduleTitle=“二甲双胍+胰岛素”vs“二甲双胍+磺脲类药物”，谁的降糖疗效和心血管结局更好？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8bdfe378177c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442195, encodeId=2ba6144219585, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=合理选择磺脲类药物，规避低血糖风险, objectType=article, longId=737612, objectId=a5efe3761254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5efe3761254, replyNumber=0, likeNumber=66, createdTime=2022-09-03, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5efe3761254, moduleTitle=合理选择磺脲类药物，规避低血糖风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a5efe3761254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442194, encodeId=8c7514421944d, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=二肽基肽酶-4抑制剂与两种磺脲类药物的联合使用有助于胰岛β细胞数的正常化, objectType=article, longId=737058, objectId=6fece3705883, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fece3705883, replyNumber=0, likeNumber=106, createdTime=2022-08-28, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fece3705883, moduleTitle=二肽基肽酶-4抑制剂与两种磺脲类药物的联合使用有助于胰岛β细胞数的正常化, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6fece3705883)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442193, encodeId=85261442193eb, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险, objectType=article, longId=737027, objectId=7b6ee370276e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b6ee370276e, replyNumber=0, likeNumber=109, createdTime=2022-08-27, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b6ee370276e, moduleTitle=磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7b6ee370276e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442192, encodeId=7fa31442192b0, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=磺脲类药物预处理可减少糖尿病患者基底节出血和血周水肿风险, objectType=article, longId=736995, objectId=2bade36995dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bade36995dc, replyNumber=0, likeNumber=96, createdTime=2022-08-27, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bade36995dc, moduleTitle=磺脲类药物预处理可减少糖尿病患者基底节出血和血周水肿风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2bade36995dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442191, encodeId=a3f7144219133, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=“一石二鸟”——磺脲类药物在治疗“牙周炎-糖尿病”共病中的作用, objectType=article, longId=736991, objectId=dd8ee369912a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd8ee369912a, replyNumber=0, likeNumber=94, createdTime=2022-08-27, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd8ee369912a, moduleTitle=“一石二鸟”——磺脲类药物在治疗“牙周炎-糖尿病”共病中的作用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dd8ee369912a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442190, encodeId=e5b31442190ac, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=磺脲类降糖药格列美脲与格列本脲的种种不同, objectType=article, longId=736567, objectId=71c5e365674e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71c5e365674e, replyNumber=0, likeNumber=94, createdTime=2022-08-24, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71c5e365674e, moduleTitle=磺脲类降糖药格列美脲与格列本脲的种种不同, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=71c5e365674e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442188, encodeId=e2ab14421888c, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究, objectType=article, longId=736517, objectId=930ce36517e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=930ce36517e1, replyNumber=0, likeNumber=97, createdTime=2022-08-23, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=930ce36517e1, moduleTitle=Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=930ce36517e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442189, encodeId=173414421896f, content=<a href='/topic/show?id=802ce3883fa' target=_blank style='color:#2F92EE;'>#磺脲类#</a>, objectTitle=Diabetes Care：2型糖尿病中磺脲类药物对心脏线粒体KATP通道的特异性与主要不良心血管事件风险的关系, objectType=article, longId=736516, objectId=c6c2e3651604, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6c2e3651604, replyNumber=0, likeNumber=81, createdTime=2022-08-23, rootId=0, userName=passed water, userId=d3064911832, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6c2e3651604, moduleTitle=Diabetes Care：2型糖尿病中磺脲类药物对心脏线粒体KATP通道的特异性与主要不良心血管事件风险的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c6c2e3651604)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

磺脲类

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#糖尿病# #胰岛素# #二甲双胍# #磺脲类#

强化控糖，终身受益！《柳叶刀》：二甲双胍、胰岛素或磺脲类效用长达44年

2024-05-23发表于上海

passed water (审核中...)

前往app查看评论内容

#磺脲类#

Diabetes ：GIP和GLP-1增强磺脲类药物诱导肝细胞核因子1a突变携带者的胰岛素分泌

2022-09-12

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-磺脲类药物联合DPP-4抑制剂的疗效

2022-09-11

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-磺脲类药物联合α-糖苷酶抑制剂的疗效

2022-09-11

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-磺脲类药物联合噻唑烷二酮类药物的疗效

2022-09-11

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-磺脲类药物联合二甲双胍疗效

2022-09-11

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-常用的磺脲类药物的用法

2022-09-07

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-对于新诊断T2DM患者，磺脲类各药物单药治疗疗效

2022-09-07

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-常用的磺脲类药物有哪些

2022-09-07

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-磺脲类药物如何调整剂量?

2022-09-07

passed water (审核中...)

前往app查看评论内容

#磺脲类#

【每日播报】-磺脲类药物应用注意事项

2022-09-07

passed water (审核中...)

前往app查看评论内容

#磺脲类#

“二甲双胍+胰岛素”vs“二甲双胍+磺脲类药物”，谁的降糖疗效和心血管结局更好？

2022-09-06

passed water (审核中...)

前往app查看评论内容

#磺脲类#

合理选择磺脲类药物，规避低血糖风险

2022-09-03

passed water (审核中...)

前往app查看评论内容

#磺脲类#

二肽基肽酶-4抑制剂与两种磺脲类药物的联合使用有助于胰岛β细胞数的正常化

2022-08-28

passed water (审核中...)

前往app查看评论内容

#磺脲类#

磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险

2022-08-27

passed water (审核中...)

前往app查看评论内容

#磺脲类#

磺脲类药物预处理可减少糖尿病患者基底节出血和血周水肿风险

2022-08-27

passed water (审核中...)

前往app查看评论内容

#磺脲类#

“一石二鸟”——磺脲类药物在治疗“牙周炎-糖尿病”共病中的作用

2022-08-27

passed water (审核中...)

前往app查看评论内容

#磺脲类#

磺脲类降糖药格列美脲与格列本脲的种种不同

2022-08-24

passed water (审核中...)

前往app查看评论内容

#磺脲类#

Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究

2022-08-23

passed water (审核中...)

前往app查看评论内容

#磺脲类#

Diabetes Care：2型糖尿病中磺脲类药物对心脏线粒体KATP通道的特异性与主要不良心血管事件风险的关系

2022-08-23

科室
- - 订阅+
  - 更多科室
工具
服务